Literature DB >> 19857207

British Association of Dermatologists' guidelines for biologic interventions for psoriasis 2009.

C H Smith1, A V Anstey, J N W N Barker, A D Burden, R J G Chalmers, D A Chandler, A Y Finlay, C E M Griffiths, K Jackson, N J McHugh, K E McKenna, N J Reynolds, A D Ormerod.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19857207     DOI： 10.1111/j.1365-2133.2009.09505.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  69 in total

1.  Negative effect of immunosuppressive therapy in the performance of the QuantiFERON gold in-tube test in patients with immune-mediated inflammatory diseases.

Authors:  José M Ramos; Mar Masiá; Juan C Rodríguez; Cristina López; Sergio Padilla; Catalina Robledano; Francisco J Navarro-Blasco; Jaime Matarredona; Mariana F García-Sepulcre; Félix Gutiérrez
Journal:  Clin Exp Med       Date:  2012-06-27       Impact factor: 3.984

Review 2.  Biological therapy and dentistry: a review paper.

Authors:  Lida Radfar; Roshanak E Ahmadabadi; Farah Masood; R Hal Scofield
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2015-07-31

3.  Response to 'Kidney disease in moderate-to-severe psoriasis: a critical appraisal'.

Authors:  J Wan; J M Gelfand
Journal:  Br J Dermatol       Date:  2016-02       Impact factor: 9.302

4.  Successive sebopsoriasis, erysipelas and Koebner phenomenon.

Authors:  Manuelle Viguier; Hervé Bachelez
Journal:  CMAJ       Date:  2010-03-08       Impact factor: 8.262

5.  Biologic safety in psoriasis: review of long-term safety data.

Authors:  Yasaman Mansouri; Gary Goldenberg
Journal:  J Clin Aesthet Dermatol       Date:  2015-02

Review 6.  Neurological and Neuropsychiatric Adverse Effects of Dermatologic Medications.

Authors:  Melinda Liu; Yuan Yu M Huang; Sylvia Hsu; Joseph S Kass
Journal:  CNS Drugs       Date:  2016-12       Impact factor: 5.749

7.  Effect of etanercept therapy on psoriasis symptoms in patients from Latin America, Central Europe, and Asia: a subset analysis of the PRISTINE trial.

Authors:  L Kemeny; M Amaya; P Cetkovska; N Rajatanavin; W-R Lee; A Szumski; L Marshall; E Y Mahgoub; E Aldinç
Journal:  BMC Dermatol       Date:  2015-05-21

Review 8.  Current status and new developments in the treatment of psoriasis and psoriatic arthritis with biological agents.

Authors:  Wolfgang Weger
Journal:  Br J Pharmacol       Date:  2010-06       Impact factor: 8.739

9.  Potential role of ustekinumab in the treatment of chronic plaque psoriasis.

Authors:  Santo Raffaele Mercuri; Luigi Naldi
Journal:  Biologics       Date:  2010-05-25

10.  Update of the management of chronic psoriasis: new approaches and emerging treatment options.

Authors:  Philip M Laws; Helen S Young
Journal:  Clin Cosmet Investig Dermatol       Date:  2010-04-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.